Skip to main content

Platt David's Form 4 filing

Bioxytran, Inc (BIXT) · filed Aug 20, 2024

Accession no.
0001754429-24-000004
Filed
Aug 20, 2024, 5:10 PM ET
Trade date
Aug 15-19, 2024
Filing delay
5 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions. Open-market purchases total $197.5K. It was filed 5 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Platt DavidCIK 0001166440Director, Officer (CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 15, 2024commonPPurchaseAcquired+1,592,921$0.124+$197,522.221,675,939Indirect
Aug 19, 2024commonJOtherDisposed−21,675,939$0.162−$3,511,502.120Indirect
Aug 19, 2024preferredJOtherAcquired+4,335,188$0.806+$3,494,161.534,335,188Indirect
Aug 19, 2024preferredCConversionAcquired+8,973,405$0.018+$161,521.2913,308,593Indirect
Aug 19, 2024preferredJOtherAcquired+776,817$0.456+$354,228.5514,085,410Indirect
Aug 19, 2024commonJOtherDisposed−411,300$0.001−$411.30Indirect
Aug 19, 2024preferredJOtherAcquired+82,260$0.005+$411.382,260Indirect
Aug 19, 2024commonJOtherDisposed−43,027,274$0.001−$43,027.270Direct
Aug 19, 2024preferredJOtherAcquired+8,605,455$0.005+$43,027.288,605,455Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)